Department of Drug Metabolism, Pharmacokinetics and Bioanalysis, AbbVie Inc., North Chicago, IL, 60064, USA.
Department of Drug Metabolism, Pharmacokinetics and Bioanalysis, AbbVie Inc., North Chicago, IL, 60064, USA.
J Chromatogr A. 2019 Nov 22;1606:460379. doi: 10.1016/j.chroma.2019.460379. Epub 2019 Jul 26.
Three different components that impact carryover in a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method were evaluated to establish baseline conditions for analyzing in vivo samples for twelve monophosphate prodrug compounds and their corresponding parent compounds. The three components were: wash solvent modifier, column shell material (metal vs. metal free), and tubing composition. These components were tested for their impact on system carryover by using rat plasma extracted samples. It was determined that a wash solution containing hexylamine yielded the lowest average carryover of the solutions tested. In addition, metal free columns and PEEK (poly ether ether ketone) tubing yielded the lowest carryover when compared to metal columns, stainless steel tubing and nickel tubing. These conditions were also tested against the parent molecules for each prodrug in the test set, to ensure that changing the conditions for the prodrugs did not impact the ability to analyze the parent, since there is typically a desire to measure both compounds in study samples. Under all conditions, the carryover of the corresponding parent molecule was not adversely impacted in these studies.
三种不同的因素会影响液相色谱-串联质谱(LC-MS/MS)方法中的残留,本研究旨在确定分析十二种单磷酸前药化合物及其相应母体化合物的体内样品的基线条件。这三个因素分别是:清洗溶剂改性剂、柱壳材料(金属与无金属)和管材料。通过使用大鼠血浆提取样品来测试这些因素对系统残留的影响。结果表明,含有己胺的清洗溶液产生的残留最低。此外,与金属柱、不锈钢管和镍管相比,无金属柱和 PEEK(聚醚醚酮)管的残留最低。这些条件还针对测试集中的每个前药的母体分子进行了测试,以确保改变前药的条件不会影响分析母体的能力,因为通常希望在研究样本中同时测量两种化合物。在所有条件下,这些研究中均未观察到相应母体分子的残留受到不利影响。